Simponi and Ear buzzing - a phase IV clinical study of FDA data

Summary:

Ear buzzing is reported as a side effect among people who take Simponi (golimumab), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Actemra, and have Neuropathy peripheral.

The phase IV clinical study analyzes which people have Ear buzzing when taking Simponi. It is created by eHealthMe based on reports of 86,103 people who have side effects when taking Simponi from the FDA, and is updated regularly.

What is Simponi?

Simponi has active ingredients of golimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 86,327 Simponi users. Check the latest studies of Simponi.

What is Ear buzzing?

Ear buzzing is found to be associated with 2,418 drugs and 3,078 conditions by eHealthMe. Check the latest studies of Ear buzzing.

On Sep, 26, 2025

86,103 people reported to have side effects when taking Simponi.
Among them, 119 people (0.14%) have Ear buzzing.

Among these 119 people:

How long have people been on Simponi when they have Ear buzzing? *

What is the gender of people who have Ear buzzing when taking Simponi? *

female: 71.15 %
male: 28.85 %

What is the age of people who have Ear buzzing when taking Simponi? *

What are other drugs people take besides Simponi? *

What are other side effects people have besides Ear buzzing? *

Headache (pain in head): 35 people, 29.41%
Drug Ineffective: 35 people, 29.41%
Joint Pain: 29 people, 24.37%
Joint Swelling: 25 people, 21.01%
Inflammation: 24 people, 20.17%
Stress And Anxiety: 22 people, 18.49%
Hyperhidrosis (abnormally increased sweating): 20 people, 16.81%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 20 people, 16.81%
Heart Rate Increased: 20 people, 16.81%
Weight Increased: 19 people, 15.97%

What are the existing conditions these people have? *

Pain: 11 people, 9.24%
Neuropathy Peripheral (surface nerve damage): 11 people, 9.24%
Birth Control: 10 people, 8.40%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 9 people, 7.56%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 2.52%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 1.68%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 1.68%
Drug Resistance (reduction in effectiveness of a drug): 2 people, 1.68%
Uveitis (inflammation of the uvea): 1 person, 0.84%
Asthma: 1 person, 0.84%

* Approximation only. Some reports may have incomplete information.

Do you take Simponi and have Ear buzzing?

- Check whether Ear buzzing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Simponi:

Simponi (86,327 reports)

Ear buzzing treatments and more:

Ear buzzing (58,542 reports)

Browse all side effects of Simponi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common drugs associated with Ear buzzing:

Browse all the drugs that are associated with Ear buzzing:

Ear buzzing (2,418 drugs)

Common conditions associated with Ear buzzing:

Depression: 3,635 reports
Antidepressant therapy: 3,623 reports
Hypertension: 2,663 reports
Hbp: 2,652 reports
Ra: 1,927 reports
Anxiety: 1,913 reports
Anxiety and stress: 1,912 reports
Pain exacerbated: 1,795 reports
Alternative medicine - pain relief: 1,778 reports
Hypercholesterolaemia: 1,671 reports

Browse all the conditions that are associated with Ear buzzing:

Ear buzzing (3,078 conditions)

Drugs similar to Simponi and Ear buzzing :

Related publications that referenced our studies

Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .
Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .

How the study uses the data?

The study uses data from the FDA. It is based on golimumab (the active ingredients of Simponi) and Simponi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.